Results 161 to 170 of about 44,697 (263)
Activation of Escherichia coli RecA* in recA730 lexA<sup>+</sup> and recA730 lexA(Def) strain backgrounds. [PDF]
McDonald JP +3 more
europepmc +1 more source
Safety of Venom Immunotherapy in Pregnancy: A Multicentre Study
Venom immunotherapy (VIT) during pregnancy, when maintenance dose is well tolerated, can be continued. No increased risk of adverse effects to VIT or safety concerns for the pregnancy or the newborns were observed. No decreased efficacy of VIT, in case of re‐stings, was reported.
Matteo Martini +20 more
wiley +1 more source
Insights to Orientation Dependence of Molecular Conduction Modeled by High-Level Quantum Embedding. [PDF]
Jelenfi DP +3 more
europepmc +1 more source
Clinical Features of Cellular Senescence Pathways in Severe Asthma
In bronchial biopsies, SASP and p53 pathway enrichment scores are elevated in severe asthma versus non‐severe asthma and healthy controls. SASP enrichment is validated in the independent NOVA cohort. SASP enrichment is also elevated in nasal brushings of participants with nasal polyps, independently of asthma status.
Woo‐Jung Song +122 more
wiley +1 more source
Serum SOS1 as a prognostic biomarker and therapeutic target for progressive liver disease. [PDF]
Amadi PU +16 more
europepmc +1 more source
The effect of hyper-induced SOS response on evolution in Escherichia coli. [PDF]
Zhao R +4 more
europepmc +1 more source
Transformation of the Agrarian Landscape and Hope in the Central Kalimantan Peatlands
ABSTRACT In Kalimantan, Indonesian Borneo, agrarian state programs and corporate strategies seek to transform indigenous Ngaju Dayak into sedentary farmers. Focusing on the notion of transformation, the paper traces whether and how rural people can engage in struggles against structural injustices.
Anu Lounela
wiley +1 more source
The SOS Response: A Double-Edged Sword between the Persister and Resister Formation. [PDF]
Ravikumar K, Kurthkoti K.
europepmc +1 more source
Cardiotoxicity of BRAF/MEK inhibitors
Abstract Rapidly accelerated fibrosarcoma type B/B‐Raf proto‐oncogene, serine/threonine kinase (BRAF) and mitogen‐activated protein kinase (MEK) inhibitors have transformed outcomes in cancer therapy, particularly in melanoma. However, cardiovascular toxicities are increasingly recognized in real‐world clinical practice.
Katharina Seuthe +4 more
wiley +1 more source

